Cutaneous or Subcutaneous Lymph Node
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB09037 | Pembrolizumab | 1 / 2 | Completed | 1 |
| DB13896 | Talimogene laherparepvec | 1 / 2 | Completed | 1 |
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB09037 | Pembrolizumab | 1 / 2 | Completed | 1 |
| DB13896 | Talimogene laherparepvec | 1 / 2 | Completed | 1 |